GlassScriptPhysician profile
Stephanie Doherty
NPI 1275102667
$2,099.14
in general payments reported to CMS, 2019-2025
22 companies · $374 in 2025
The $374 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $392 · 2023: $798 · 2024: $535 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,636 · Education: $71.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,635.79 |
| Education | $71.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $383.42 | 2022-2025 | |
| Novo Nordisk INC | $319.87 | 2022-2024 | Rybelsus, Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $165.74 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Astellas Pharma US INC | $156.57 | 2022-2023 | Myrbetriq, Veozah |
| Sumitomo Pharma America, INC. | $124.46 | 2023 | Gemtesa |
| Amgen INC. | $121.13 | 2022-2025 | Otezla, Repatha, Otezla |
| Medtronic, INC. | $120.70 | 2025 | Symplicity G3 |
| Lilly USA, LLC | $100.18 | 2022-2024 | Mounjaro, Jardiance, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.14 | 2022-2025 | Jardiance |
| Pfizer INC. | $80.43 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.59 | 2023-2024 | |
| Baxter Healthcare | $61.29 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Lundbeck LLC | $56.23 | 2022-2023 | Rexulti |
| Exact Sciences Corporation | $53.60 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $34.00 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $32.90 | 2022-2023 | Quviviq |
| Merck Sharp & Dohme LLC | $29.33 | 2023-2024 | Gardasil 9, Pneumovax 23, Vaxneuvance |
| Phathom Pharmaceuticals, INC. | $25.31 | 2024 | Voquezna |
| Sunovion Pharmaceuticals INC. | $24.33 | 2022 | |
| Janssen Scientific Affairs, LLC | $20.74 | 2022 | |
| Mylan Specialty L.P. | $18.43 | 2024 | Yupelri |
| Janssen Pharmaceuticals, INC | $14.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Doherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.